Anaemia in myelofibrosis: its value in prognosis
- 1 May 1983
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 54 (1), 79-89
- https://doi.org/10.1111/j.1365-2141.1983.tb02069.x
Abstract
Patients (44) with myelofibrosis were investigated. Their clinical, laboratory and radioisotope parameters were analyzed. The direct correlation between plasma volume and splenic red cell pool has highlighted the role of the spleen in the dilutional anemia seen in myelofibrosis. 52Fe quantitation showed that the bone marrow contributes relatively more to effective erythropoiesis than the extramedullary sites. The prognostic value of changes in plasma volume and bone marrow 52Fe activity was demonstrated. The Hb:reticulocyte relationship at diagnosis can be used to recognize probable stages of the disease and provides a useful prognostic determinant.This publication has 13 references indexed in Scilit:
- Erythropoiesis in Myelofibrosis with Myeloid Metaplasia: Recognition of Different Classes of Patients by ErythrokineticsBritish Journal of Haematology, 1981
- The Pathogenesis of Myelofibrosis in Myeloproliferative DisordersAnnals of Internal Medicine, 1980
- Erythrokinetic Studies in Myelofibrosis: Their Significance for PrognosisBritish Journal of Haematology, 1978
- Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosisBlood, 1978
- Erythroid Hypoplasia in Myelofibrosis: a Feature Associated with Blastic TransformationBritish Journal of Haematology, 1977
- Quantitative Studies of Splenic Erythropoiesis in Polycythaemia Vera and MyelofibrosisBritish Journal of Haematology, 1976
- THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROMEMedicine, 1971
- Studies of Splenic Function in the Myeloproliferative Disorders and Generalized Malignant LymphomasBritish Journal of Haematology, 1971
- MYELOFIBROSIS CLINICAL, HEMATOLOGIC AND PATHOLOGIC STUDY OF 110 PATIENTSThe American Journal of the Medical Sciences, 1962
- Editorial: Some Speculations on the Myeloproliferative SyndromesBlood, 1951